Thermal stress involved in TRPV2 promotes tumorigenesis through the pathways of HSP70/27 and PI3K/Akt/mTOR in esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

Thermal stress involved in TRPV2 promotes tumorigenesis through the pathways of HSP70/27 and PI3K/Akt/mTOR in esophageal squamous cell carcinoma

Published:2022-07-27 Issue:8 Volume:127 Page:1424-1439
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Huang Rongqi,Li Shuai,Tian Chao,Zhou Peng,Zhao Huifang,Xie Wei,Xiao Jie,Wang Ling,Habimana Jean de Dieu,Lin Zuoxian,Yang Yuchen,Cheng Na,Li Zhiyuan^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s41416-022-01896-2.pdf

Reference69 articles.

1. Florea A, Sangaré L, Lowe K. A multinational assessment of gastric, esophageal, and colorectal cancer burden: a report of disease incidence, prevalence, and fatality. J Gastrointest Cancer. 2020;51:965–71.

2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.

3. Ma G, Zhang J, Jiang H, Zhang N, Zhu Y, Deng Y, et al. Microvessel density as a prognostic factor in esophageal squamous cell cancer patients: a meta-analysis. Medicine. 2017;96:e7600.

4. Domper Arnal MJ, Ferrández Arenas Á, Lanas Arbeloa Á. Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol. 2015;21:7933–43.

5. Castellsagu´e X, Munoz N, Stefani E. Influence of mate drinking, hot beverages and diet on esophageal cancer risk in south America. Int J Cancer. 2000;88:658–64.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Igniting hope: Harnessing NLRP3 inflammasome-GSDMD-mediated pyroptosis for cancer immunotherapy;Life Sciences;2024-10

2. Functional and structural insights into activation of TRPV2 by weak acids;The EMBO Journal;2024-04-26

3. NY-ESO-1-specific T cell receptor-engineered T cells and Tranilast, a TRPV2 antagonist bivalent treatment enhances the killing of esophageal cancer: a dual-targeted cancer therapeutic route;Cancer Cell International;2024-02-09

4. TRPV2 inhibitor tranilast prevents atrial fibrillation in rat models of pulmonary hypertension;Cell Calcium;2024-01

5. The role of TRPV2 as a regulator on the osteoclast differentiation during orthodontic tooth movement in rats;Scientific Reports;2023-08-22